ABL Bio Inc. (KOSDAQ:298380)
South Korea · Delayed Price · Currency is KRW 93,900
-1,500 (-1.57%)
Oct 10, 2025, 3:30 PM KST
ABL Bio Market Cap
ABL Bio has a market cap or net worth of 5.18 trillion as of October 10, 2025. Its market cap has increased by 291.04% in one year.
Market Cap
5.18T
Enterprise Value
5.08T
Revenue
94.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
93,900.00
Market Cap Chart
Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 5.18T, an increase of 750.50%. That is a compound annual growth rate of 36.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 5,176.25B | 258.56% |
| Dec 30, 2024 | 1,443.63B | 22.53% |
| Dec 28, 2023 | 1,178.16B | 7.19% |
| Dec 29, 2022 | 1,099.13B | 5.54% |
| Dec 30, 2021 | 1,041.42B | -27.59% |
| Dec 30, 2020 | 1,438.26B | 31.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 19, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |